中华老年医学杂志
中華老年醫學雜誌
중화노년의학잡지
Chinese Journal of Geriatrics
2015年
10期
1080-1083
,共4页
王蕊%陈涓%李春媚%娄宝辉%彭丹涛%周进元%张晨%陈敏
王蕊%陳涓%李春媚%婁寶輝%彭丹濤%週進元%張晨%陳敏
왕예%진연%리춘미%루보휘%팽단도%주진원%장신%진민
磁共振成像%阿尔茨海默病%认知障碍%氨基质子转移
磁共振成像%阿爾茨海默病%認知障礙%氨基質子轉移
자공진성상%아이자해묵병%인지장애%안기질자전이
Magnetic resonance imaging%Alzheimer's disease%Cognition disorders%Amide proton transfer
目的 评价磁共振酰胺质子转移(APT)成像技术在诊断阿尔茨海默病(AD)和遗忘型轻度认知功能障碍(aMCI)患者脑异常改变的可行性,并进一步探讨该技术的临床应用价值. 方法 21例AD患者(AD组)、11例aMCI患者(aMCI组)和19例年龄及性别相匹配的健康对照者(对照组)进行头颅常规磁共振结构像和APT成像检查.在斜轴位APT像上测量双侧海马、颞叶白质、枕叶白质和大脑脚的酰胺质子(3.5 ppm处)不对称磁化转移率(MTRasym).采用单因素方差分析比较3组间各脑结构MTRasym(3.5 ppm)值的差异.以年龄和受教育时间为控制变量,采用偏相关分析比较所有受试者各脑结构MTRasym(3.5 ppm)值与简易精神状态量表(MMSE)评分的相关性.结果 正常对照组、MCI组和AD组双侧海马的MTRasym(3.5 ppm)值依次增高,右侧:(0.86±0.32)%、(1.15±0.31)%和(1.42±0.35)%(F=13.712,P=0.000);左侧:(0.84±0.31)%、(1.14±0.32)%和(1.39±0.33)%(F=12.835,P=0.000).双侧海马的MTRasym(3.5ppm)值均与MMSE评分呈负相关(右侧r=-0.595,P=0.000;左侧r=-0.552,P=0.000). 结论 APT成像能够敏感地显示AD和MCI患者海马区基于蛋白增加的脑代谢异常.
目的 評價磁共振酰胺質子轉移(APT)成像技術在診斷阿爾茨海默病(AD)和遺忘型輕度認知功能障礙(aMCI)患者腦異常改變的可行性,併進一步探討該技術的臨床應用價值. 方法 21例AD患者(AD組)、11例aMCI患者(aMCI組)和19例年齡及性彆相匹配的健康對照者(對照組)進行頭顱常規磁共振結構像和APT成像檢查.在斜軸位APT像上測量雙側海馬、顳葉白質、枕葉白質和大腦腳的酰胺質子(3.5 ppm處)不對稱磁化轉移率(MTRasym).採用單因素方差分析比較3組間各腦結構MTRasym(3.5 ppm)值的差異.以年齡和受教育時間為控製變量,採用偏相關分析比較所有受試者各腦結構MTRasym(3.5 ppm)值與簡易精神狀態量錶(MMSE)評分的相關性.結果 正常對照組、MCI組和AD組雙側海馬的MTRasym(3.5 ppm)值依次增高,右側:(0.86±0.32)%、(1.15±0.31)%和(1.42±0.35)%(F=13.712,P=0.000);左側:(0.84±0.31)%、(1.14±0.32)%和(1.39±0.33)%(F=12.835,P=0.000).雙側海馬的MTRasym(3.5ppm)值均與MMSE評分呈負相關(右側r=-0.595,P=0.000;左側r=-0.552,P=0.000). 結論 APT成像能夠敏感地顯示AD和MCI患者海馬區基于蛋白增加的腦代謝異常.
목적 평개자공진선알질자전이(APT)성상기술재진단아이자해묵병(AD)화유망형경도인지공능장애(aMCI)환자뇌이상개변적가행성,병진일보탐토해기술적림상응용개치. 방법 21례AD환자(AD조)、11례aMCI환자(aMCI조)화19례년령급성별상필배적건강대조자(대조조)진행두로상규자공진결구상화APT성상검사.재사축위APT상상측량쌍측해마、섭협백질、침협백질화대뇌각적선알질자(3.5 ppm처)불대칭자화전이솔(MTRasym).채용단인소방차분석비교3조간각뇌결구MTRasym(3.5 ppm)치적차이.이년령화수교육시간위공제변량,채용편상관분석비교소유수시자각뇌결구MTRasym(3.5 ppm)치여간역정신상태량표(MMSE)평분적상관성.결과 정상대조조、MCI조화AD조쌍측해마적MTRasym(3.5 ppm)치의차증고,우측:(0.86±0.32)%、(1.15±0.31)%화(1.42±0.35)%(F=13.712,P=0.000);좌측:(0.84±0.31)%、(1.14±0.32)%화(1.39±0.33)%(F=12.835,P=0.000).쌍측해마적MTRasym(3.5ppm)치균여MMSE평분정부상관(우측r=-0.595,P=0.000;좌측r=-0.552,P=0.000). 결론 APT성상능구민감지현시AD화MCI환자해마구기우단백증가적뇌대사이상.
Objective To evaluate the feasibility of amide proton transfer (APT) MR imaging for the detection of cerebral metabolite abnormalities in patients with Alzheimer's disease (AD) and amnestic mild cognitive impairment (aMCI),and to explore its clinical utility.Methods Totally 21 AD patients,11 aMCI patients and 19 age-and sex-matched normal controls underwent APT and structural MR imaging.The magnetic resonance ratio asymmetry (MTRasym) values at 3.5 ppm of bilateral hippocampi,temporal white matter regions,occipital white matter regions and cerebral peduncles were measured on the oblique axial APT MR images.The differences in MTRasym (3.5ppm) values of the cerebral structures among the three groups were compared by using one-way ANOVA.After adjusting for age and years of education,partial correlation analysis was used to investigate the associations between mimi-mental state examination (MMSE) scores and the various MR imaging measures among all the groups.Results MTRasym (3.5ppm) in bilateral hippocampi showed a consistently increasing trend from normal controls to MCI and to AD,right:(0.86 ±0.32)%,(1.15±0.31)% and (1.42±0.35)% (F=13.712,P=0.000);left:(0.84±0.31)%,(1.14±0.32)% and (1.39±0.33)% (F=12.835,P=0.0000).MTRasym (3.5 ppm) values of bilateral hippocampi were significantly negatively correlated with MMSE scores (right:r=-0.595,P=0.000;left:r=-0.552,P=0.000).Conclusions APT MR imaging can sensitively show abnormal cerebral metabolites because of the increased proteins and peptides in the hippocampus in patients with AD and MCI,which suggests the technique is a useful tool to diagnose early AD and monitor the disease.